These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8388580)

  • 21. The topology of plasminogen binding and activation on the surface of human breast cancer cells.
    Andronicos NM; Ranson M
    Br J Cancer; 2001 Sep; 85(6):909-16. PubMed ID: 11556845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional analysis of the amino- and carboxyl-termini of streptokinase.
    Fay WP; Bokka LV
    Thromb Haemost; 1998 May; 79(5):985-91. PubMed ID: 9609234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assay of functional plasminogen in rat plasma applicable to experimental studies of thrombolysis.
    Bangert K; Thorsen S
    Thromb Haemost; 2000 Aug; 84(2):299-306. PubMed ID: 10959704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
    Vines DJ; Lee SW; Dichek DA; Ellis V
    J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Facilitation of plasminogen activation by a plasmin substrate containing a lysyl residue.
    Machovich R; Owen WG
    Thromb Haemost; 1993 Nov; 70(5):864-6. PubMed ID: 8128447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Symposium on anisoylated plasminogen streptokinase activator complex (APSAC). Proceedings of an international symposium. Guernsey, 5-6 November 1986.
    Drugs; 1987; 33 Suppl 3():1-316. PubMed ID: 3315573
    [No Abstract]   [Full Text] [Related]  

  • 27. The binding and processing of plasminogen by Balb/c 3T3 and SV3T3 cells.
    Tobler J; Krieger M; Stroud RM
    J Cell Physiol; 1981 Aug; 108(2):277-90. PubMed ID: 6267086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The urokinase receptor is a major vitronectin-binding protein on endothelial cells.
    Kanse SM; Kost C; Wilhelm OG; Andreasen PA; Preissner KT
    Exp Cell Res; 1996 May; 224(2):344-53. PubMed ID: 8612711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasminogen binding and activation at the breast cancer cell surface: the integral role of urokinase activity.
    Stillfried GE; Saunders DN; Ranson M
    Breast Cancer Res; 2007; 9(1):R14. PubMed ID: 17257442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The preclinical toxicology of anisoylated plasminogen streptokinase activator complex.
    Artus JA; Cockburn A; Fuller J; McMurdo AS; White DJ
    Drugs; 1987; 33 Suppl 3():97-101. PubMed ID: 3315619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional hierarchy of plasminogen kringles 1 and 4 in fibrinolysis and plasmin-induced cell detachment and apoptosis.
    Ho-Tin-Noé B; Rojas G; Vranckx R; Lijnen HR; Anglés-Cano E
    FEBS J; 2005 Jul; 272(13):3387-400. PubMed ID: 15978044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug eruptions and isotypic antibody responses to streptokinase after infusions of anisoylated plasminogen-streptokinase complex (APSAC, anistreplase).
    Dykewicz MS; McMorrow NK; Davison R; Fintel DJ; Zull CC; Rutledge JL
    J Allergy Clin Immunol; 1995 May; 95(5 Pt 1):1020-8. PubMed ID: 7751498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.
    Mazzieri R; Masiero L; Zanetta L; Monea S; Onisto M; Garbisa S; Mignatti P
    EMBO J; 1997 May; 16(9):2319-32. PubMed ID: 9171346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasminogen binding properties of macrophage inflammatory protein (MIP)-2alpha.
    Arza B; Félez J; Fábregas P; Laroche Y; Collen D; Lijnen HR
    Thromb Haemost; 2000 Jul; 84(1):71-7. PubMed ID: 10928473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antifibrinolytic activities of alpha-N-acetyl-L-lysine methyl ester, epsilon-aminocaproic acid, and tranexamic acid. Importance of kringle interactions and active site inhibition.
    Anonick PK; Vasudevan J; Gonias SL
    Arterioscler Thromb; 1992 Jun; 12(6):708-16. PubMed ID: 1375508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasminogen binds to plasmin-modulated factor Xa by Ca(2+) - and C-terminal lysine-dependent and -independent interactions.
    Grundy JE; Hancock MA; Meixner SC; MacKenzie RC; Koschinsky ML; Pryzdial EL
    Thromb Haemost; 2007 Jan; 97(1):38-44. PubMed ID: 17200769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Demonstration of covalent binding of lipoprotein(a) [Lp(a)] to fibrin and endothelial cells.
    Liu JN; Kung W; Harpel PC; Gurewich V
    Biochemistry; 1998 Mar; 37(11):3949-54. PubMed ID: 9521716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of a group A Streptococcus within human plasma results in assembly of a surface plasminogen activator that contributes to occupancy of surface plasmin-binding structures.
    D'Costa SS; Boyle MD
    Microb Pathog; 1998 Jun; 24(6):341-9. PubMed ID: 9632538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of cell-associated plasminogen activation by stromelysin-1 (MMP-3).
    Ugwu F; Lemmens G; Collen D; Lijnen HR
    Thromb Haemost; 1999 Sep; 82(3):1127-31. PubMed ID: 10494776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3).
    Ugwu F; Van Hoef B; Bini A; Collen D; Lijnen HR
    Biochemistry; 1998 May; 37(20):7231-6. PubMed ID: 9585535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.